We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 1,103

IOM report on salt recommendations draws criticism

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 17 2013

The Institute of Medicine (IOM) recently issued a report assessing the scientific evidence behind government recommendations that adults in the

New studies focus on sodium and calorie content of restaurant and processed foods

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 17 2013

Three recent studies published in JAMA Internal Medicine have analyzed the nutritional content of restaurant and processed foods, raising questions

Biotech receives $32.5 million for cancer research

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

Celator Pharmaceuticals, Inc., a Princeton, New Jersey-based company that develops cancer therapies, has raised $32.5 million in the final closing of

Congress advances pharma supply chain and animal-drug user-fee laws

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

The House Energy and Commerce Subcommittee on Health has reportedly approved draft legislation that would change the existing lot-level

News Bytes - May 16, 2013

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

The National Institutes of Health (NIH) Office of Biotechnology Activities proposes revising the "NIH Guidelines for Research Involving Recombinant

Universities abroad experiment with no-fee licensing to drive biotech partnerships

  • Shook Hardy & Bacon LLP
  • -
  • Australia, Canada, European Union, United Kingdom, USA
  • -
  • May 16 2013

Universities in Australia, Canada, Europe, and the United Kingdom have reportedly embraced a 2010 Glasgow University initiative under which companies

NASDAQ Biotechnology Index surpasses all-time high in 1Q13

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

The NASDAQ Biotechnology Index reportedly rose in the first quarter of 2013 (1Q13) above levels last seen during the 2000 genomics bubble peakthe

Putative class alleges pharma statements about new drug violated securities laws

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

Aveo Pharmaceuticals, Inc. and several of its executives have been targeted in a securities class action filed in a federal court in Massachusetts

ANSI circulates draft nanotechnology standards panel meeting report

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 10 2013

The American National Standards Institute (ANSI) has circulated a draft report of its most recent Nanotechnology Standards Panel meeting. Established

Nanoparticles in everyday items inhibit fat storage and accelerate aging

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 10 2013

New research conducted by Stony Brook University scientists reportedly reveals that "pure gold nanoparticles found in everyday items such as personal

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy